. Author manuscript; available in PMC: 2015 Nov 1.

Published in final edited form as: J Crohns Colitis. 2014 May 3;8(11):1378–1391. doi: 10.1016/j.crohns.2014.04.003

Table 1.

Baseline characteristics of controls and patients with ulcerative colitis (UC) at inclusion. 5ASA = Mesalazine, GC = Glucocorticoids, IFX = Infliximab, AZA = Azathioprine.

	N	Mean age years	Male N (%)	Mayoscore Mean [CI]	5ASA N (%)	GC N (%)	IFX N (%)	AZA N (%)
Controls	15	55	7 (47%)	0	0	0	0	0
UC	33	44	13 (39%)	8.3 [7.4–9.2]	28 (85%)	8 (24%)	5 (15%)	2 (1%)